Blog
RSS FeedPosted by Michael Wonder on 13 May 2021
Long waits for life saving drugs harming Canadians: report
13 May 2021 - Canadians wait 15 months longer on average for new and potentially life-saving medications compared to Americans ...
Posted by Michael Wonder on 05 May 2021
Canadian agency recommends Ruzurgi be reimbursed with conditions
5 May 2021 - CADTH has recommended that Ruzurgi (amifampridine) be reimbursed for the treatment of Lambert-Eaton myasthenic syndrome in ...
Posted by Michael Wonder on 29 Apr 2021
Bavencio receives reimbursement recommendation from pCODR and INESSS for the maintenance treatment of patients with advanced bladder cancer
29 April 2021 - EMD Serono Canada and Pfizer Canada are pleased to announce that Bavencio (avelumab for injection) has received ...
Posted by Michael Wonder on 29 Apr 2021
Valeo Pharma’s Redesca and Redesca HP to be covered under the Ontario Public Drug Benefit Program
28 April 2021 - Additional provincial coverage expected to follow. ...
Posted by Michael Wonder on 29 Mar 2021
B.C. woman petitions province to cover cost of 'life-changing' migraine medication
29 March 2021 - Christina Sall says Aimovig is the only drug that helps her, but it costs her more than ...
Posted by Michael Wonder on 29 Mar 2021
Alberta family waiting on approval for expensive, life-saving drug for young boy
23 March 2021 - Reign Johnston turned 2 on March 5. One of his grandpas and an uncle came to ...
Posted by Michael Wonder on 19 Mar 2021
Cystic fibrosis patients call on Premier Ford to provide immediate access to life saving treatments
18 March 2021 - Ontarians with cystic fibrosis made an emotional plea to Premier Ford this week in a video that ...
Posted by Michael Wonder on 25 Feb 2021
AbbVie’s Skyrizi for the treatment of moderate to severe plaque psoriasis now publicly reimbursed across Canada
24 February 2021 - Prince Edward Island lists Skyrizi on its Pharmacare Formulary effective 22 February 2021. ...
Posted by Michael Wonder on 21 Feb 2021
Ontario makes commitment to funding CF drugs after approval process completed
19 February 2021 - Ontario’s Health Minister Christine Elliott says life-saving cystic fibrosis medications that are inching their way through ...
Posted by Michael Wonder on 18 Feb 2021
Fresenius Kabi Canada launches Idacio (adalimumab injection) a biosimilar to Humira (adalimumab) for the treatment of multiple chronic inflammatory conditions
18 February 2021 - Biosimilars offer patients access to affordable, meaningful medicines ...
Posted by Michael Wonder on 18 Feb 2021
HLS Therapeutics provides update on private and public payer reimbursement for Vascepa
16 February 2021 - Active negotiations have also begun with the pan-Canadian Pharmaceutical Alliance for reimbursement of Vascepa by publicly funded ...
Posted by Michael Wonder on 11 Feb 2021
Cystic fibrosis advocate asks P.E.I. to fast-track coverage of new 'mind-blowing' drug
10 February 2021 - ‘It’s the closest thing we’ve ever had to a cure’. ...
Posted by Michael Wonder on 10 Feb 2021
New drugs entering Canada at steady rate over past 5 years - Canada still among top 10 OECD countries in terms of access to new drugs
10 February 2021 - The latest edition of the Patented Medicine Prices Review Board Meds Entry Watch reports that 40 new-to-Canada ...
Posted by Michael Wonder on 28 Jan 2021
Alberta announces funding for pricey gene therapy drug Zolgensma
Alberta Health Minister Tyler Shandro announced funding Wednesday for the gene therapy Zolgensma, which is used to treat toddlers with ...
Posted by Michael Wonder on 04 Jan 2021
ALS patients and advocates say Canada needs better access to new treatments
3 January 2020 - 'The clock is ticking for us,' says a Niagara man who has ALS, and has joined the ...